Windgap Medical
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Angel | ||
N/A | Grant | ||
$1.5m | Seed | ||
$1.0m | Debt | ||
$60.0k | Seed | ||
$4.2m | Series A | ||
$11.0k | Debt | ||
N/A | N/A | Convertible | |
* | $12.1m | Late VC | |
$3.2m | Grant | ||
$17.0m | Series B | ||
* | $39.0m | Series B | |
Total Funding | €70.1m |
Related Content
Recent News about Windgap Medical
EditWindgap Medical is a pioneering company in the healthcare sector, specializing in the development of advanced medical devices designed to improve the quality of life for patients with severe allergies. The company operates in the medical device market, focusing on creating user-friendly, portable solutions that allow patients to manage their conditions more effectively and with greater freedom. Windgap Medical's business model revolves around the research, development, and commercialization of these cutting-edge devices. Revenue is generated through the sale of their products to healthcare providers, pharmacies, and directly to consumers. The company has received significant recognition and funding, including awards from the Massachusetts Life Sciences Center and the Massachusetts Medical Device Development Center. These accolades underscore Windgap Medical's commitment to innovation and excellence in the medical device industry.
Keywords: medical devices, severe allergies, healthcare, innovation, quality of life, portable solutions, commercialization, funding, Massachusetts, life sciences.